Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Bolm L, Pisuchpen N, Qadan M, Kambadakone A, Sondermann S, Mueller K, Petruch N, May K, Zelga P, Nebbia M, Michelakos T (2022) Prediction of R status in resections for pancreatic cancer using simplified radiological criteria. Ann Surg 276:215–221. https://doi.org/10.1097/SLA.0000000000005433
2. National Comprehensive Cancer Network (NCCN) (2022) NCCN Clinical Practice Guidelines in Oncology Pancreatic Adenocarcinoma, version 1.2022. https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf. Accessed 25 July 2022
3. Hayasaki A, Isaji S, Kishiwada M, Fujii T, Iizawa Y, Kato H, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Mizuno S (2018) Survival analysis in patients with pancreatic ductal adenocarcinoma undergoing chemoradiotherapy followed by surgery according to the International Consensus on the 2017 definition of borderline resectable cancer. Cancers (Basel) 10:65. https://doi.org/10.3390/cancers10030065
4. Murakami Y, Satoi S, Sho M, Motoi F, Matsumoto I, Kawai M, Honda G, Uemura K, Yanagimoto H, Shinzeki M, Kurata M (2015) National Comprehensive Cancer Network resectability status for pancreatic carcinoma predicts overall survival. World J Surg 39:2306–2314. https://doi.org/10.1007/s00268-015-3096-3
5. Hoshimoto S, Hishinuma S, Shirakawa H, Tomikawa M, Ozawa I, Wakamatsu S, Hoshi S, Hoshi N, Hirabayashi K, Ogata Y (2017) Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer. Eur J Surg Oncol 43:1068–1075. https://doi.org/10.1016/j.ejso.2017.03.020
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献